
CAS 1520010-86-9
:Sofosbuvir IMpurity
Description:
Sofosbuvir impurity, identified by its CAS number 1520010-86-9, is a chemical compound associated with the antiviral drug Sofosbuvir, which is primarily used in the treatment of hepatitis C. As an impurity, it may arise during the synthesis or degradation of Sofosbuvir and is typically characterized by its molecular structure, which may include specific functional groups that influence its chemical behavior. Impurities like this can affect the efficacy and safety of pharmaceutical formulations, making their identification and quantification crucial in drug development and quality control processes. The characteristics of such impurities often include their solubility in various solvents, stability under different conditions, and potential biological activity. Regulatory agencies require thorough analysis of impurities to ensure that they do not exceed acceptable limits in pharmaceutical products. Understanding the properties of Sofosbuvir impurity is essential for ensuring the overall quality and safety of the final drug product.
Formula:C12H18NO5P
Synonyms:- Sofosbuvir Phosphate Impurity
- Sofosbuvir Phenoxyphosphinyl Impurity
- Sofosbuvir IMpurity
- L-Alanine, N-(hydroxyphenoxyphosphinyl)-, 1-methylethyl ester
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
Sofosbuvir Impurity 43 Cyclohexylamine Salt
CAS:Formula:C12H18NO5P·C6H13NColor and Shape:White To Off-White SolidMolecular weight:287.25 99.18Isopropyl N-(Hydroxyphenoxyphosphinyl)alaninate Sodium Salt
CAS:Controlled Product<p>Applications Isopropyl N-(Hydroxyphenoxyphosphinyl)alaninate Sodium Salt is an impurity of Sofosbuvir (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.<br>References Lam, A.M.,et al.: Antimicrob. Agents. Chemotherapy., 56, 3359 (2012); Lam, A.M., et al.: J. Virol., 85, 12334 (2011); Sofia, M.J., et al.: J. Medn. Chem., 53, 7202 (2010);<br></p>Formula:C12H17NNaO5PColor and Shape:NeatMolecular weight:309.23

